Timing is everything: finding the safest moment for blood thinners after a stroke
NCT ID NCT06753786
Summary
This study aims to find the best and safest time to start a blood-thinning medication (heparin) in patients who have had a brain bleed caused by high blood pressure. Researchers want to know if starting the drug within the first two days or waiting until the third day is better at preventing dangerous blood clots in the legs or lungs, while also being less likely to cause more bleeding in the brain. They will compare these two timing strategies in 200 patients to see which one offers the best balance of benefits and risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moscow City Clinical Hospital named after V.M. Buyanov
RECRUITINGMoscow, 115516, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.